<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wilson TL</submitter><funding>NIAID NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIH</funding><funding>NRSA-NIAID</funding><funding>NIH NCI</funding><pagination>2098-2119</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9437573</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(9)</volume><pubmed_abstract>Current chimeric antigen receptor-modified (CAR) T-cell products are evaluated in bulk, without assessing functional heterogeneity. We therefore generated a comprehensive single-cell gene expression and T-cell receptor (TCR) sequencing data set using pre- and postinfusion CD19-CAR T cells from blood and bone marrow samples of pediatric patients with B-cell acute lymphoblastic leukemia. We identified cytotoxic postinfusion cells with identical TCRs to a subset of preinfusion CAR T cells. These effector precursor cells exhibited a unique transcriptional profile compared with other preinfusion cells, corresponding to an unexpected surface phenotype (TIGIT+, CD62Llo, CD27-). Upon stimulation, these cells showed functional superiority and decreased expression of the exhaustion-associated transc</pubmed_abstract><journal>Cancer discovery</journal><pubmed_title>Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages.</pubmed_title><pmcid>PMC9437573</pmcid><funding_grant_id>P30CA021765</funding_grant_id><funding_grant_id>F32 AI157296</funding_grant_id><funding_grant_id>P30 CA021765</funding_grant_id><funding_grant_id>R01 AI136514</funding_grant_id><funding_grant_id>F32AI157296</funding_grant_id><funding_grant_id>R01AI136514</funding_grant_id><funding_grant_id>U01AI150747</funding_grant_id><funding_grant_id>U01 AI150747</funding_grant_id><pubmed_authors>Metais JY</pubmed_authors><pubmed_authors>Mettelman RC</pubmed_authors><pubmed_authors>Lockey T</pubmed_authors><pubmed_authors>Kim H</pubmed_authors><pubmed_authors>Allen EK</pubmed_authors><pubmed_authors>Talleur AC</pubmed_authors><pubmed_authors>Wilson TL</pubmed_authors><pubmed_authors>Gottschalk S</pubmed_authors><pubmed_authors>Triplett BM</pubmed_authors><pubmed_authors>Minervina AA</pubmed_authors><pubmed_authors>Meagher MM</pubmed_authors><pubmed_authors>Trivedi S</pubmed_authors><pubmed_authors>Chou CH</pubmed_authors><pubmed_authors>Riberdy JM</pubmed_authors><pubmed_authors>Pogorelyy MV</pubmed_authors><pubmed_authors>Crawford JC</pubmed_authors><pubmed_authors>Velasquez MP</pubmed_authors><pubmed_authors>Olsen SR</pubmed_authors><pubmed_authors>Willis C</pubmed_authors><pubmed_authors>Thomas PG</pubmed_authors><pubmed_authors>Langfitt D</pubmed_authors><pubmed_authors>Kottapalli P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages.</name><description>Current chimeric antigen receptor-modified (CAR) T-cell products are evaluated in bulk, without assessing functional heterogeneity. We therefore generated a comprehensive single-cell gene expression and T-cell receptor (TCR) sequencing data set using pre- and postinfusion CD19-CAR T cells from blood and bone marrow samples of pediatric patients with B-cell acute lymphoblastic leukemia. We identified cytotoxic postinfusion cells with identical TCRs to a subset of preinfusion CAR T cells. These effector precursor cells exhibited a unique transcriptional profile compared with other preinfusion cells, corresponding to an unexpected surface phenotype (TIGIT+, CD62Llo, CD27-). Upon stimulation, these cells showed functional superiority and decreased expression of the exhaustion-associated transc</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2026-05-28T07:02:02.827Z</modification><creation>2025-04-06T09:24:17.025Z</creation></dates><accession>S-EPMC9437573</accession><cross_references><pubmed>35792801</pubmed><doi>10.1158/2159-8290.CD-21-1508</doi></cross_references></HashMap>